Commerce Bank lifted its holdings in STERIS plc (NYSE:STE - Free Report) by 22.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 6,968 shares of the medical equipment provider's stock after buying an additional 1,300 shares during the quarter. Commerce Bank's holdings in STERIS were worth $1,432,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Magnolia Capital Advisors LLC boosted its stake in STERIS by 1.9% in the fourth quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider's stock valued at $521,000 after acquiring an additional 48 shares during the period. SkyView Investment Advisors LLC lifted its holdings in shares of STERIS by 1.6% in the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock worth $765,000 after purchasing an additional 51 shares during the last quarter. Park Edge Advisors LLC boosted its position in STERIS by 1.1% during the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider's stock valued at $958,000 after purchasing an additional 51 shares during the period. Citizens Financial Group Inc. RI grew its stake in STERIS by 5.9% during the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider's stock worth $201,000 after buying an additional 54 shares during the last quarter. Finally, Opal Wealth Advisors LLC increased its position in STERIS by 5.7% in the fourth quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider's stock worth $230,000 after buying an additional 60 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the stock. Piper Sandler boosted their price target on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Stephens reaffirmed an "overweight" rating and set a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Finally, JMP Securities reiterated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $258.75.
Get Our Latest Stock Analysis on STE
STERIS Price Performance
Shares of NYSE STE traded down $1.35 during mid-day trading on Friday, reaching $225.00. 368,819 shares of the company traded hands, compared to its average volume of 526,071. STERIS plc has a fifty-two week low of $200.98 and a fifty-two week high of $248.24. The firm has a market cap of $22.11 billion, a PE ratio of 47.77 and a beta of 0.87. The stock has a fifty day simple moving average of $222.89 and a 200-day simple moving average of $218.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40.
STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities research analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.
STERIS Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. STERIS's dividend payout ratio is currently 48.41%.
About STERIS
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Recommended Stories

Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.